United States · FDA National Drug Code directory

GABAPENTIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-3057_6af55316-950c-402a-b479-4fdf6bc662cd
Product NDC
71335-3057
Form
TABLET
Composition / generic term
Gabapentin
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20211001
Source listing expiry
20271231

Source-listed ingredients

  • GABAPENTIN — 800 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (71335-3057-1) · 71335-3057-1
  • 60 TABLET in 1 BOTTLE (71335-3057-2) · 71335-3057-2
  • 90 TABLET in 1 BOTTLE (71335-3057-3) · 71335-3057-3
  • 180 TABLET in 1 BOTTLE (71335-3057-4) · 71335-3057-4
  • 120 TABLET in 1 BOTTLE (71335-3057-5) · 71335-3057-5
  • 100 TABLET in 1 BOTTLE (71335-3057-6) · 71335-3057-6
  • 84 TABLET in 1 BOTTLE (71335-3057-7) · 71335-3057-7
  • 112 TABLET in 1 BOTTLE (71335-3057-8) · 71335-3057-8
  • 135 TABLET in 1 BOTTLE (71335-3057-9) · 71335-3057-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →